Semaglutide linked to 26% lower 5-year predicted dementia risk
Semaglutide is associated with a 26% reduction in the predicted risk of developing dementia over five years. This finding suggests potential cognitive benefits of the drug beyond its use for weight management and diabetes.
alz-journals.onlinelibrary.wiley.com
1 min
8/15/2026
Semaglutide linked to 26% lower 5-year predicted dementia risk
Semaglutide is associated with a 26% reduction in the predicted risk of developing dementia over five years. This finding suggests potential cognitive benefits of the drug beyond its use for weight management and diabetes.
alz-journals.onlinelibrary.wiley.com
1 min
8/15/2026
Semaglutide linked to 26% lower 5-year predicted dementia risk
Semaglutide is associated with a 26% reduction in the predicted risk of developing dementia over five years. This finding suggests potential cognitive benefits of the drug beyond its use for weight management and diabetes.
alz-journals.onlinelibrary.wiley.com
1 min
8/15/2026
No more articles to load